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Abstract: Type 1 Diabetes Mellitus (DM1) is a metabolic disease that is characterized by chronic
hyperglycemia due to a lack of pancreatic insulin production. This forces patients to perform several
blood glucose measurements per day—by means of capillary glucometers—in order to infer a trend and
try to predict future values. In this way, a decision about the insulin dosage that has to be exogenously
injected to maintain glycemia within the desirable levels is made. Unfortunately, this method usually
suffers from relatively high imprecision. However, recent advances in information and communication
technologies (ICT), along with novel biosensors that could provide a real-time comprehensive condition
of the patient, offer a new perspective in DM1 management. In this sense, new disruptive technologies
like Big Data, the Internet of Things (IoT), and Cloud Computing, as well as Machine Learning (ML)
can play an important role in managing DM1. In this work, firstly, an analysis of previously published
ICT-based methods for the management of diabetes continuous monitoring is carried out. In this way,
an assessment of the possible lack of such proposals is presented, along with the challenges to be
overcome in forthcoming smart DM1 management systems. Finally, an overview of a holistic ICT-based
platform for DM1 management that try to solve the limitations of previous works, while at the same
time, taking advantage of the abovementioned disruptive technologies is hereby proposed.
Keywords: diabetes mellitus management; wearable sensors; information and communication technologies
1. Introduction
Type 1 Diabetes Mellitus (DM1) is a disease characterized by high blood sugar levels that result
from the body’s inability to produce and/or use insulin. In a healthy human, glucose homeostasis
represents a closed-loop system that is able to regulate the blood glucose levels. The pancreas presents
β cells that are sensitive to high glucose levels and produce insulin, a strong hormone that is able to
reduce hyperglycemia.
This regulation is not possible in DM1, since it is an auto-immune disease in which the body
destroys the insulin-producing cells in the pancreas. In this sense, DM1 is the more chronic form of
diabetes. Patients with DM1 do not produce any insulin and must exogenously inject this hormone—or
wear an insulin pump—in order to reduce their glucose levels. Moreover, patients affected by diabetes
need to check their glucose level several times per day (through capillary glucometers), so that,
based on these data, as well as other factors, like meals, exercise, and many others, they can decide
when to inject insulin and how much is required to avoid hyperglycemia. Insulin can be delivered
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either by multiple daily injections or by continuous infusion, using a pump, which permeates under
the skin.
In this context, new technological possibilities offer a new horizon in diabetes management.
Although the first steps towards an artificial pancreas (AP) were undertaken 50 years ago [1], when the
concept of a computer-supported system emulating the behavior of a pancreas by using a control
algorithm was introduced, promising that technological advances achieved in recent years are
supposed to bring a revolution in this field. Nowadays, an AP (which has not been completely
achieved yet) is presumed to be composed of a Continuous Glucose-Monitoring (CGM) device aimed
at checking the patient’s glucose levels in real time (a feature that is already available) and injecting
(a feature that is not yet commercially available) insulin (and glucagon, if applicable) into his or her
body, along with a control system based on a closed loop, which must decide the amount of hormone
(insulin or glucagon) to be injected [2,3].
2017 was a particularly significant year regarding the AP [4]. Clinical trials were performed
and their results were published, showing a good performance under real and demanding situations.
Even a commercial hybrid closed-loop system is commercially available at present, Medtronic MiniMed
670G, which automatically adjusts basal insulin every five minutes based on CGM readings and is able
to stop insulin up to 30 min before reaching a preset low limit. It also automatically restarts insulin
when patient’s levels recover [5]. Nowadays, in this field, a total of 18 different closed-loop AP systems
were identified as being in clinical phase development [6].
On the other hand, beyond the AP and CGM devices, others in the field of biometrics make it
possible to maintain 24-h monitoring of the patient, thus recording important information about his
or her health that could be interesting and properly used in a DM1 management context. Variables,
like temperature, exercise, heart rate, and perspiration, among others, can be monitored continuously.
However, the inclusion of new monitored features simultaneously generates a large amount of
information and creates a new problem: the need to handle it in an appropriate information and
communication technologies (ICT) framework that is designed to collect and gather data, process
it, and obtain useful knowledge. In this sense, well-known improvements in computer science are
able to tackle these challenges, and, at this point, technologies like smartphones and ideas, like the
Internet of Things (IoT), Big Data, and Cloud Computing arise, which are powerful options for dealing
with a huge quantity of information. In this sense, recent developments have introduced both the
idea of a Body Area Network (BAN)—along with some other sensors—to gather relevant information
and the use of platforms to display data and ease the diabetes management [7]. This way, the most
relevant approaches in this field have been properly summarized by Lanzola et al. [8]. Nonetheless,
although they are really valuable contributions, the consideration of some ICT possibilities that are
available at present (such as smartbands, smartwatches and so on), is not taken into account, and going
further, a comprehensive focusing of all the previous contributions, thus leading to a lack of features
regarding a complete platform for DM1 management. Furthermore, some recent approaches to
model and predict blood glucose concentration, as well as insulin boluses (with decision support),
which have been recently and successfully developed [9–12] could be considered and included into a
more holistic perspective.
Therefore, for the stated purpose, there is a need for a platform that provides a framework in which
the mentioned possibilities in diabetes management are properly exploited to the highest level, allowing
for a complete, comprehensive, and holistic management, developed in real time. Therefore, in this
work, an analysis of existing ICT-based methods for the management of diseases which need continuous
monitoring (with an emphasis on DM1) is carried out. Then, an evaluation of the possible lack of such
proposals is presented, along with the challenges that should be overcome in forthcoming smart DM1
management systems. Finally, a new ICT-based platform for DM1 management, which takes advantage
of recent computer science technologies is proposed.
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2. ICT-Based Approaches for the Management of Diseases Which Need Permanent Monitoring
(With an Emphasis on DM1)
2.1. Telemedicine
In the scientific literature, some approaches that ease the management of some illnesses by taking
advantage of the possibilities of ICT can be found, especially those that need permanent monitoring,
as is the case in DM1.
A body area network (BAN) is a wireless network of wearable computing devices that are
widely used in remote monitoring in telemedicine. A BAN represents all of the applications and
communications on, in and near the body, so it is a necessary approach to be taken into account in
telemedicine. One of the most attractive applications to use BANs is the monitoring of physiological
signals from patients in the medical environment. On the other hand, a wireless body-area network
(WBAN) is a special purpose wireless-sensor network that incorporates different networks and wireless
devices to enable remote monitoring for various environments. The idea of a BAN is introduced in [13],
focusing on epilepsy sufferers. Via a 24-h monitoring method, the system aims to notify the person of
the possibility of an epileptic attack. In this way, such paper could suggest, in a DM1 context, the need
to predict glucose evolution and alert not only the patient but also health professionals via the Internet
or mobile phone in case of emergency. However, this proposal could be completed with a proper
information-exchange platform, as also occurs in [14].
When using a BAN, we need a device that is able to play the role of a Body Gateway and a
Network Hub. This device is easily identified with a smartphone. The possibilities of this device in
diabetes management have already been pointed out initially in [15]. In this work, some data on food
and insulin—along with location and activity—are registered in the phone so that glucose patterns can
be identified and advice about insulin doses can be offered by the smartphone. However, nowadays,
technology makes it easy to wear more precise biometric sensors to successfully connect all of them and
to obtain a good comprehension. However, a smartphone can help not only being a simple gateway
but also it can further be considered a tool to manage information. A review of how new applications
designed for smartphones can help in diabetes management is presented in [16]. In this work, we can
see that so far, applications are limited and focus on some specific part of the management (tracking
physical activity, glycemia control, etc.), but there is no complete perspective of the problem.
On the other hand, currently, it is not possible to think about an approach to an artificial pancreas
without considering a CGM device. This mechanism has led to a revolution in diabetes care [17],
since it can provide the magnitude, tendency, frequency, and duration of the fluctuations of the
glucose levels in diabetic patients. When compared with conventional glucose monitoring (fingerstick,
capillary blood glucose monitoring), which can provide between three and ten measures of glucose
per day, CGM can deliver up to one measure per minute (1440 data per day). Therefore, this is a
sample frequency which is sufficient to be the input of a control system, although Kovatchev et al. [18]
indicate that CGM still bears some limitations, such as transient loss of sensitivity and random noise.
The novelties in this area are continuously arising. In 2014 the release of the flash glucose monitoring
system Freestyle Libre, Abbott Laboratories, involved somehow a revolution due to its accuracy and
affordability [19]. The possibilities of these devices, with regard to connectivity, are still growing.
Regarding the problem of the management of information, a promising work related to diabetes
management is reported in [20], where a healthcare platform for type 2 diabetes is presented, also using
smartphones. In this proposal, different information is collected, such as physical activity, heart
rate, or amount of food. It is able to show activity goals, activity states, and dietary records.
Nonetheless, the proposed system uses uncomfortable sensors, and some important features are
not measured, like glycemia. Furthermore, it is not able to deal with risky situations. In fact, in diabetes
management, this is an important issue, mainly due to the risk that is involved in a hypoglycemia.
In [21], an alarm-based mobile diabetes management system (ADMAN) is proposed. By using remote
monitoring, it is aimed at improving diabetes control in elderly patients. Although it includes an
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emergency system, most of the features are not monitored and there is no prediction of future glycemia
levels. Other good examples on data management using smartphones are iBGSTAR®, manufactured
by Sanofi (Paris, France), in combination with the Diabetes Manager app, also from Sanofi, or the G5
Mobile CGM System by Dexcom Inc. (San Diego, CA, USA).
The IoT is proposed as a good environment for diabetes management in [22]. Smartphones are
proposed for remote collection and monitoring of data, with feedback for the patient and medical
caregivers. Although such work is a complete proposal, some of the features are not monitored,
and, what is more, CGM is not included. In another vein, the proposed model tries to modify, through
advice, the patient’s insulin dosage, but it should be noted that, without 24-h monitoring, this could
not be carried out 100% successfully.
Advancements in cloud computing are proposed in [23] for diabetes control. In this case, the cloud
provides an easy way to exchange information, but unfortunately full monitoring and management of
emergency situations is missing.
On the other hand, it should be mentioned another approach, called COMMODITY12 [7], which is
presented as a personal-health system to assist diabetic patients. This proposition consists of wearable
and portable devices that acquire vital body signs, which are interpreted by algorithms based on
expert knowledge. Active feedback goes directly to the patient or health professionals. Although
it is an interesting proposal that includes physical activity and heart rate, it could be completed
with other features from biosensors. Expert knowledge is used to interpret data, but the potential of
other machine learning methods may be bigger; for instance, they may be able to predict glycemia
or to make autonomous decisions. These tasks are not expected in this system, not even to avoid
hypoglycemia. Lastly, the lack of inclusion of CGM in the monitoring, which should be an essential
part, is an omission that needs to be rectified. A similar weakness can be found in [24]. Although the
development of a BAN is complete, including others features that are usually non-considered (like
body temperature, for example) and there is an online display to offer information, there should be a
generation of knowledge.
Finally, it is necessary to deal with the acceptance level of telemedicine. A continuous monitoring,
recording personal data, and a complete characterization of the patient could be considered as an
interference in private life. This could lead to an attitude of rejection from the user. These issues are
compiled in [25]. In this work, it is explained that variables, like age, gender, and previous experiences
with telemedicine can modulate its level of acceptance.
So, after this review, we can conclude that, in order to develop a complete DM1 management
system, it is necessary for a BAN to collect data, which should include glycemia and insulin, but also
other kind of relevant features, like heart rate, physical activity, or slept hours. Moreover, a smartphone
is a cornerstone to play the role of a Body Gateway, and also could provide enhanced information
thanks to some software applications. Finally, IoT and Cloud Computing will allow for remote
management, and the entire system must provide auto-adjustment, decision support, and advice to
the patient, when considering machine learning algorithms or deep learning procedures.
As previously mentioned, a complete review of these systems has been presented recently in [8],
offering an interesting overview of the current scenario and the previous attempts. Nonetheless,
a complete approach for diabetes management that includes a complete characterization of the patient’s
state as well as knowledge discovery—in an ICT environment—is missed.
2.2. Methods of Connection
Taking advantage of new continuous biometric sensors will create a technological structure in the
patient that will generate a huge amount of data. Initially, it has to be ensured that the systems have
enough compatibility between clinical devices, platform management, and computerized records in
medical institutions in order to promote the sharing of data. This interoperability includes biosensors,
which have to be ready to send collected data in an understandable way. In this sense, an accepted
criterion is Health Level 7 (HL7) [26], which is the most important standard for the transfer of clinical
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and administrative data between software applications used by various healthcare providers. It defines
a method of moving clinical data between independent medical applications in near real time.
Initially, some approaches like Mobile Access to Health Information (MAHI) [27] introduced
interaction between diabetic patients and medical staff through a phone connected by Bluetooth to a
glucometer. Unfortunately, asynchronous communications meant that it was impossible to generate
advice and warnings in real time.
Managing data is a distinctive issue in Wireless Sensor Networks, where the main feature is the
mobility of the source of the information [28]. Low-power body area networks can be a solution, because
of their low power consumption and their mobility features. Today, these wireless communications can
be hosted on smartphones, namely Bluetooth Low Energy (BLE), as well as Near Field Communication
(NFC) or WiFi. An example can be health monitoring of patients in their bedrooms [29].
As described above, several types of new sensors have burst onto the technological landscape,
and this means there is a broad range of different communications requirements in the IoT environment.
Therefore, the chosen method of transmitting data must allow for high continuous data transmission,
low consumption, high payload size, and sufficient bandwidth. To achieve this, some approaches
have been followed previously. The problem of energy saving in a heath monitoring system
with smartphones is studied in [30]. Taking advantage of Zigbee and Bluetooth communications,
low wastage of energy is achieved. However, such work is not focused on any disease in particular, and
the study of forecasted situations is omitted. ZigBee and Bluetooth have been implemented successfully
in low-power wireless body area networks with discrete sensors, such as blood pressure monitors
and weighing scales [31]. Others with greater complexity like pulse oximeters or electrocardiograms
have been simplified by reducing the sample frequency [32]. Recently, NFC has been proven as a
proper choice to monitor glycemia in the successful device Abbot Freestyle Libre, a flash blood glucose
monitoring system with a popularity constantly raising in the past two years [19].
To provide inter-operability between devices, Continua Alliance (C.A.) has defined proper
communications protocols, like the Bluetooth Health Device Profile (HDP), which ensures a reliable
and secure way to transmit information. This ecosystem uses IEEE 1073 standards to define their
protocols and create compatibility [33]. Although these standards have also been described by C.A.
for ZigBee, some medical sensors are not still developed, such as electrocardiograms (ECG), due to
their complexity. Notwithstanding, important researches have successfully taken place by using a
6LoWPAN approach [34] as well as NFC [35]. In any case, these three methods (Bluetooth, ZigBee,
NFC) provide a convenient IoT environment, which will be described later.
2.3. Communications Environment
In order to connect the IoT devices to the cloud for the processing of data, it is essential to provide
a communications infrastructure with channels for transmitting a large amount of data. In this way,
nowadays, the connection possibilities have been expanded and it is possible to find a wide range of
ways to transmit information. Providing devices with a Wi-Fi transmitter can open new perspectives
that will allow an increase in connectivity between medical equipment. However, out of the range
of a Wi-Fi net, which can be available in a patient’s home or, for instance, in a hospital environment,
it will be necessary to rely on a smartphone 4G connection to launch data to the cloud. In any case, it is
possible to provide self and independent connections to every device through its own SIM cards.
The communication between the devices can also be based on Bluetooth, which, in the form of
BLE, is a promising way to gather information. This is the communication technology proposed in
the architecture presented in this paper. BLE has been designed taking into account the requirements
of the IoT, allowing for the transmission of data without the need to establish a connection, so that
the pairing and transfer are faster (3 ms). Therefore, in a discrete transmission, sensors can sleep and
wake up periodically to transmit, which involves a saving of energy. BLE is able to develop several
functions, from the gathering of data to remote management.
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Other types of connections are also interesting alternatives. ZigBee is an IEEE 802.15.4—based
specification for a suite of high-level communication protocols that are used to create personal area
networks with small, low-power digital radios, such as for home automation, medical device data
collection, and other low-power low-bandwidth needs that are designed for small-scale projects
that need wireless connection. It is intended to be simpler and less expensive than other wireless
personal area networks (WPANs), and it is able to connect more than 65,000 nodes with a lower
energy consumption because the nodes can go sleep when they are not in use. However, in our case,
that number of nodes is not necessary and the sensors cannot be deactivated because monitoring is
carried out 24 h per day.
On the other hand, NFC is a set of communication protocols that enable two electronic devices to
establish communication by bringing them close to each other. By now, this technology is in use in the
Abbott Freestyle Libre CGM device. Another possibility can come from ANT+, which is a wireless
technology that encourages interoperability and open access to data between different manufacturers
of smartphones, diagnostics, power meters, heart rate monitors, remote control systems, and so on.
In view of the above, it can be noticed that different problems regarding the interconnection
between all of the devices involved in a smart diabetes monitoring system could arise due to a lack of
communication compatibility. Such fact has been properly analyzed in [14]. Furthermore, it should be
noted that the proprietary software/protocols and the companies policies could also represent some
barriers in the creation of an integrated system In this sense, it is fare to mention the efforts of the
Nightscout Project [36], an open source, “do-it-yourself” project that allows for real time access to a
CGM data via personal website, smartwatch viewers, or apps and widgets available for smartphones.
It was developed by parents of children with DM1 and has continued being developed, maintained,
and supported by volunteers.
3. Challenges to be Overcome in an ICT—Based Diabetes Management System
After a complete review of the scientific literature, it is possible to identify some characteristics to
be improved in order to draft a holistic solution for management of DM1 by means of ICT technologies.
Firstly, the potential of CGM as a masterpiece in diabetes control and management is still
unfolding. Unfortunately, this device has not been developed enough until recent years. Even today,
the CGM devices that are available on the market present some problems, such as lack of accuracy,
decalibration, and sometimes a short usable period. Moreover, complaints are frequently made about
the lag time between the data provided by the CGM and the real glucose level in the bloodstream of
the patient. This is due to the fact that the CGM is not measuring directly from the blood; the value that
the CGM device offers is an estimate based on the interstitial fluid glucose that exists under the skin,
whose magnitude is delayed by some minutes with respect to the actual value that are present in the
bloodstream. This fact can be perceived as a disadvantage. However, recent research has found that
this lag time is not more than 5–10 min [37]. Moreover, mathematical methods can suitably compensate
for the lack of accuracy due to this delay. In fact, some of the tests deployed by Basu [38] confirm
a delay of just six minutes. Luckily, novel technologies in this area make more reliable, affordable,
and user-friendly devices possible. This will necessarily lead to an increasing number of studies that
include CGM in innovative diabetes management analysis.
In another vein, it is remarkable that previous works suffer from the absence of global monitoring
of the patient. Moreover, apart from the obvious features that have an impact on diabetes control
(glycemia itself, insulin, meals), studies have proven that other variables can influence glycemia trends
significantly. For example, physical activity is widely assumed to be an influencing variable [39],
and its monitoring is starting to be essential in diabetes management, usually being recorded with
accelerometers. Heart-rate is also an emerging feature that is beginning to be considered as a required
variable for a realistic diabetes management system. However, the potential of this component is
often undervalued and is usually related only to hypoglycemia [40]. Other variables, such as exhaled
breath [41] or polarimetry to monitor changes in the aqueous humor of the eye [42], have been studied,
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but such research is only at an early stage. On the other hand, other variables whose consideration
makes intuitive sense are studied, at most, in a controlled environment under laboratory conditions
of temperature, perspiration, and so on, and in isolation. Others, like the influence of schedule
or weekday, are well-known [43], but have not been studied in the context discussed in this work.
Therefore, to the best of the authors’ knowledge, there is not a global study in which all of them are
monitored at the same time.
In addition, the way in which these features are treated lacks an expanded vision. Some variables,
like insulin, could be treated in different ways, for instance, from an “on board” perspective, both basal
insulin and remaining fast-insulin, which can act with low (but noticeable) intensity for several hours,
are taken into account. Although this concept has been introduced for insulin, it could be extended
similarly to other features. This possibility has not been studied yet.
Going further, it has not been possible for the authors of this paper to find a work that compares
and ranks the importance of all of the features that have an impact on diabetes control and offers a
definitive set of variables that are to be taken into account.
The potential of new improvements in ICT has still not been exploited to its full extent. To begin
with, a uniform way to deal with information is needed, and in this sense, approaches like the
mentioned HL7 have established a path to follow. In any case, the diversity of communication
channels, including WiFi, ZigBee, 6LowPAN, and BLE, offers several options that need to be studied
and specified.
Smartphones, at this moment, present a level of adaptability that is difficult to reach for any other
device, due to their versatility, growing power, connectivity, and mobility options. They allow for us to
make the software responsible for modeling the dynamics of the system, performing glucose prediction,
optimizing the solution and controlling the process, and also managing information between CGM
devices and an insulin pump, thanks to the possibilities of their connectivity [44]. Other features are
also interesting, like forward emergency calls in case of risk to the patient providing the location,
via GPS [45], or actualize its software when required. However, there are some doubts about the
approval of smartphones as medical devices (class III, high risk). The controller application installed
in the phone has to be reliable enough, avoiding opposition with other applications running in the
device. Other circumstances, such as an eventual discharge of battery or a loss of connectivity, must be
prevented. These pros and cons are properly discussed in [46].
Groundbreaking advances in electronics have introduced miniaturization and more powerful
innovations in biometrics, the field in which measurable biological characteristics are studied.
Nowadays, it is possible to measure certain variables, most of them vital signs, in a continuous mode,
such as heart rate, exercise, and others. All of these measurements take part in the complex blood glucose
balance and must be taken into account. Some years ago, it was difficult to obtain a compilation of data
for a full day, but nowadays, different devices like smartbands, smartwatches, and other fitness and
medical wearables make this objective easy, offering a lot of useful information [47]. These disruptive
innovations have potential in the field of healthcare and have been studied recently. Nonetheless,
restrictions due to size, battery length, and the fact that these devices are sometimes conceived for other
use than that by healthcare professionals casts some doubts about their accuracy [48]. In such work,
their usefulness in DM1 management is one of the ideas, which is discussed.
Modeling techniques based on artificial intelligence methods open the possibility of predicting
glycaemia and thus anticipating actuation and trying to follow the different steps of the so-called
Kowalski path [49], which describes the stages that are to be followed in order to obtain an artificial
pancreas. Unfortunately, such methods have not been studied under the preceding considerations.
In this sense, the fields of work that have been opened are immense and promising. Implementing
a predictive model in order to forecast the evolution of the patient is something highly desirable.
It could anticipate risky situations or even provide a decision support. Unluckily, the development
and validation of models using Machine Learning techniques requires the collection of clinical data,
which should be preferably carried out at different centers to ensure that the models are well-calibrated
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to different populations of patients. Going further, the model needs to be auto-adaptable to changes
in the health and routine of the patient, avoiding wrong predictions, and, consequently, undesirable
situations. Anyway, an initial stage of development of an ICT-based platform would help in the data
collection and the testing stage, even allowing a test environment where patients would be under
observation, minimizing the risks.
Finally, after reviewing the existing telemedicine platforms proposals, a scheme able to deal with
novel ICT advances, while at the same time, exploiting all of their possibilities is lacking. For instance,
some of the existing platforms connect patients and medical staff, but do not offer an optimized
solution, do not take into account a suboptimal features set, or do not consider the ability to manage
emergency situations.
It is time to aim for a complete management system and, with the aim of synthesizing the previous
considerations; it is possible to summarize the above in terms of the following challenges:
• Full sensor integration. Technological advances have introduced new sensors, some of them
specifically designed for diabetes care and others conceived for health information generally.
These devices use different means of transmitting information. Therefore, it is necessary to create
a platform that is able to deal with all of them successfully.
• Novel ways to deal with information, generating new variables. The need to include the “on
board” concept in other features has been studied. Moreover, it is necessary to generate, in a
consistent way, a definitive features set that differentiates the importance and relevance of the
different variables.
• Pattern identification/prediction of glycemia. Being able to identify patterns enables us to make
predictions. In this sense, glycemia prediction is the most interesting ability that is mentioned in
this work. A reliable forecast allows for the anticipation of risky situations, such as hypoglycemia
or maintained hyperglycemia. In this sense, the application of Machine Learning techniques is
continually growing. Artificial Neural Networks offer an adaptive and flexible way to predict
glycemia or give some advice about the insulin dosage [12].
• Optimized solutions. With the previous step solved, it is possible to offer a suggestion about
insulin dosage or health tips. Global diabetes management will advise about insulin injections
(with the proper dosage), which will always require the user’s approval, thus avoiding the
misfortune of wrong decisions. Going further, the platform needs to be able to identify suboptimal
situations, for instance, a sedentary lifestyle or lack of rest. Using a cloud computing resource,
the complexity of the computerized models and the optimization process can be overcome
without limitations.
• Management of a big amount of data. CGM usually provides data with a periodicity that ranges
from 1 to 5 min. Other sensors previously mentioned, for instance, a heart-rate monitor, should also
capture data in the range of minutes. This leads to the generation of a huge amount of data that have
been compiled at short intervals. Thus, it is a good decision to introduce Big Data analysis [50,51].
This is a concept that applies to data sets that are so large or complex that traditional data-processing
applications become useless. Some challenges in this field include analysis, capture, search, sharing,
storage, transfer, visualization, querying, updating, and information privacy. The term “Big Data”
often refers simply to the use of predictive analytics or certain other advanced methods in order to
extract value from the data. It is easy to find examples of the use of this resource in health care to
add useful knowledge to the obtained data [52].
• Emergency control. Under certain circumstances, the diabetes platform needs to take control of
the situation. The main dangerous situation is strong hypoglycemia, which can lead to a loss of
consciousness, or, in extreme cases, death. To mitigate the consequences of hypoglycemia, it is
necessary, firstly, to stop the infusion pump in the case of a diabetic person using the device,
for example, and secondly, to warn emergency services and medical staff about the status of the
patient. Moreover, the systems will provide a historical record of the last hours, including insulin
dosages, meals, and physical activity.
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• Easy inter-connection between patients, caregivers, and medical workers. In a world that is
characterized by information flows, it is mandatory to address valuable knowledge in many
directions, contacting all of the subjects involved in the diabetes management.
Multiple access points have to be available to check data and processes and to change settings,
which can be done not only via the patient’s smartphone, but also remotely via the Internet or another
smartphone (which could be useful for monitoring children or aged/impaired patients).
• User-oriented environment. In a health care context, the focus must always be on the user.
A proper interface, from a cross-platform perspective, is essential to enable patients to take
advantage of this work’s concept. Furthermore, a friendly way to provide information is necessary
when considering a population sector with special requirements, such as people with disabilities,
the elderly, or children. Customizable options will result in a good user experience.
• Privacy, security, integrity. These usual concepts in ICT frameworks are also critical in the proposal
of this work, and in fact, personal data are being processed. Therefore, control mechanisms need
to be provided in order to assure a proper management of such sensitive information [53].
Once more, it is necessary to remark that, although some previous proposals offer some of these
points, to the best of the authors’ knowledge, there is not one that is complete with all of them.
4. Towards a Complete Solution by Means of an ICT Structure
In this section, the structure of an IoT platform that is aimed at managing diabetes, modeled in
layers where different technological issues are arranged, is presented as a summary of the present work.
This structure can also be found in several areas, such as energy savings in buildings or smart services
in cities [54], but has not been employed in a diabetes management system up to now. Therefore,
as shown in Figure 1, the configuration of an integral diabetes management platform should be built
as follows:
• Biological substrate. This is the layer where the patient is located. His or her physical changes,
reflected in skin, blood, movement, and so on, will be disaggregated as variables to be measured.
This layer is where the inception of the data occurs, where it is generated, and, finally, where the
system’s outputs will actuate (via therapeutic decisions).
• Sensorization layer. Input data are acquired from a plethora of sensors, all of them connected
to an IoT framework. Sensors can be configured and controlled remotely through the Internet,
enabling a variety of monitoring applications and creating a technological structure.
• Communication layer. This tier allows for data permeation until the next stage. All of the
sensors must support several communication channels in order to connect easily. Avoiding direct
input/output (I/O) through regular wiring, Wi-Fi, 4G, ZigBee (or 6LowPAN), and Bluetooth
connections need to be available to support direct access to sensors, mainly via another smart
device (smartphone, tablet) used as a gateway, following an IoT approach. All of the elements
are connected to each other by using a little Local Area Network (LAN), and, likewise, to a
smartphone (or the cloud).
• Middleware layer. Given the heterogeneity of data sources and the necessity of a seamless
integration of devices and networks covered by the sensors and communication layer of our
architecture, a middleware mediator is needed to deal with this task. Therefore, the transformation
of the collected data from the different data sources into a common language representation is
performed in the middleware layer. As mentioned before, HL7 is a proper candidate to deal with
this task.
The ontology implemented to represent the knowledge of the bloodstream glucose level clearly
follows a user-centric approach, which takes into account all of the information characterizing the
situations, the devices and their status, and the patient himself of herself.
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• Computing and management layer. In this layer, data collected are handled in order to carry out
a data analysis, obtain a glucose prediction, and chose an optimal therapeutic solution. Here,
is where a data-processing center and modeling core are placed. Pervasive computing has to
be done on two levels: one local, in the smartphone, and another in the cloud. In this way, it is
possible to avoid the risk of lack of connection to the Internet or battery failure. Data harvested
are sent, via LAN, to a smartphone, or maybe, in some circumstances (e.g., the absence of a
smartphone), directly from the sensors to the cloud, if it is provided. Therefore, ubiquitous
computing allows for a powerful and safe way to address the problem.
• Display layer (interface). Access to the system will be via browser. Thus, the parameters can
be adjusted either by a smartphone or by a computer, local, or external, which is close to the
patient or remote for healthcare staff. Data collected are also accessible, as well as statistics and
the general status of the glycemia control system. It should be noted that the previous layer must
have reached a blood glucose (BG) prediction and an optimized solution of insulin input, and this
can be shown to the user either for information only or to await confirmation or variation.
• Outputs. With the goal of integral management, the platform, thanks to all of the data collected
and available resources, needs to be ready to cover the following exposed requirements.
Figure 1. Proposed layered structure for an artificial pancreas.
And as a result, it is possible to obtain:
• Concerning therapeutic decisions: As a consequence of data processing, artificial intelligence
modeling, and optimization processes, the platform has to be ready to offer a BG prediction as
continuous information for the patient or remote caregivers in order to forecast an undesirable
situation, adopt autonomous therapeutic decisions in a safe way in order to avoid hyperglycemia
or to maintain euglycemia (normal levels of glycemia) in well-known situations, and give
Appl. Sci. 2018, 8, 511 11 of 15
therapeutic advice, that is, create valuable knowledge offering guidelines that could be helpful to
both the patient and the clinical staff.
• Emergency management: A comprehensive management system must be ready to deal with a
risky situation. For instance, when hypoglycemia occurs, insulin delivery should be stopped and
the patient’s awareness should be checked, for example, by asking him or her and awaiting a
reaction. In case of loss of consciousness, making an automatic call to the emergency services with
a description of the situation and a GPS location would be an expected behavior of the platform.
• Clinical data exchange for caregivers: Health-care researchers can benefit from an easy and
real-time exchange of data that have been previously filtered and processed, and the platform
should then be ready to incorporate professionals’ feedback. This remote data exchange will also
enable parents (in the case of diabetic children) and elderly people’s caregivers to control from
afar and also to use automatic notifications in the case of abnormal situations.
This structure needs to be networked properly. In this sense, as can be seen in Figure 2, the system
architecture would be composed of a local gateway (smartphone) that is connected to the Internet via
4G or through a domestic WiFi. The smartphone will be exclusive for each patient. It is on the Internet
that it is possible to place the data warehouse and a processing center, as well as the modeling core.
Moreover, by using the Internet, the management of the system via a Web browser will be possible.
Figure 2. Diagram of the flows of data.
The smartphone is responsible for collecting data from the sensors. It also has to be reliable to
establish and manage connections with devices that are attached to the patient. By using several
methods of communication (BLE is a good candidate, but 6LoWPAN, NFC, and so on can also be
used), the exchange of data becomes possible so that a plethora of biometric meters can be interlinked.
BLE has been developed to have a very low consumption of energy, even lower than 6LoWPAN.
This is possible due to a simplified protocol that facilitates the scanning and a required standby time
before the transmission of data, thanks to the reduction from 16 channels to only 3 for advertising [55].
In addition, connection is faster and takes place automatically when scanning, so connection and
transmission are available in the mentioned 3 ms. The BLE peak current is under 17.5 mA, so coin
cell batteries are adequate as a power supply, which is a very important feature in the interest
of miniaturization.
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Sensors which lie on a patient’s skin could connect by using Bluetooth, NFC, or other means
of communication.
5. Conclusions
Our world is, in a very remarkable way, changing continuously thanks to technological advances.
All of these improvements have become revolutionary in a lot of areas, making life easier in many
ways. In the struggle to obtain a full, complete, and definitive way to control diabetes, some boosts
have been obtained thanks to the development of new devices like CGM devices or insulin pumps.
Notwithstanding, science has continued its advance and new systems can be found now. This work
has reviewed diabetes management architectures using modern perspectives in the area of ICT,
innovating throughout novel electronics and communications.
Some ICT platforms have been checked, showing the absence and incompleteness of existing
works. In this sense, IoT and Big Data analysis have been explained in this context, showing that these
approaches are the best candidates to improve diabetes management, that is, the best solution to deal
with such a large amount of data, and, going further, Cloud Computing plays a promising role. On the
other hand, pervasive computing will allow for the manipulation and calculation as well as helping in
medical decisions. In this sense, an ICT-based platform for DM1 management that takes advantage of
the abovementioned disruptive technologies has been proposed.
Moreover, in order to gather information, BLE has been shown to be the best solution, but other
possibilities have also been pointed out, such as WiFi, 4G, ZigBee, and others, which have been
introduced as ways to link information.
To conclude, we have been shown that it is necessary to face new challenges that come from
today’s technological reality. With this perspective, it is possible to sketch new platforms whose
schemas have been proposed, offering some guidelines that should be followed.
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